Weight loss induced by deep transcranial magnetic stimulation in obesity: A randomized, double-blind, sham-controlled study.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
08 2019
Historique:
received: 18 11 2018
revised: 26 03 2019
accepted: 03 04 2019
pubmed: 9 4 2019
medline: 17 9 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

To test the hypothesis that deep transcranial magnetic stimulation (dTMS) reduces food craving and causes weight loss via neuromodulation. This pilot study was designed as a randomized, double-blind, sham-controlled study. A total of 33 obese people (nine men, 24 women, mean age 48.1 ± 10.6 years, body mass index [BMI] 36.9 ± 4.7 kg/m The mixed-model analysis for repeated measures showed a significant interaction of time and groups for body weight (P = 0.001) and BMI (P = 0.001), with a significant body weight (-7.83 ± 2.28 kg; P = 0.0009) and BMI (-2.83 ± 0.83, P = 0.0009) decrease in the HF versus the sham group. A decreasing trend in food craving in the HF versus the LF and sham groups (P = 0.073) was observed. A significant improvement of metabolic and physical activity variables was found (P < 0.05) in the HF group. We demonstrated the safety and efficacy of dTMS, in addition to physical exercise and a hypocaloric diet, in reducing body weight for up to 1 year in obese people. We hypothesize that a possible mechanism of HF dTMS treatment is modulation of the dopaminergic pathway and stimulation of physical activity.

Identifiants

pubmed: 30957981
doi: 10.1111/dom.13741
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1849-1860

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Anna Ferrulli (A)

Endocrinology and Metabolism Department, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Concetta Macrì (C)

Endocrinology and Metabolism Department, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Ileana Terruzzi (I)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Stefano Massarini (S)

Endocrinology and Metabolism Department, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Federico Ambrogi (F)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Michela Adamo (M)

Endocrinology and Metabolism Department, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Valentina Milani (V)

Scientific Directorate, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Livio Luzi (L)

Endocrinology and Metabolism Department, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH